Access cutting-edge hepatocellular carcinoma (hcc) treatment through this clinical trial at a research site in West Los Angeles. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this West Los Angeles location
Preparing your pre-screening questions…
Access hepatocellular carcinoma (hcc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatocellular carcinoma (hcc) treatment provided free
Check if you qualify for this hepatocellular carcinoma (hcc) clinical trial in West Los Angeles, CA
No-Cost Study Care
Local to West Los Angeles
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This prospective, single-center study evaluates the clinical utility of F18-Piflufolastat (PSMA) PET/CT when added to conventional cross-sectional imaging for patients with suspected or confirmed hepatocellular carcinoma (HCC). The study aims to determine whether PSMA PET/CT improves diagnostic accuracy for indeterminate liver lesions (LI-RADS 3 and 4), enhances staging precision in treatment-naïve patients, and provides more accurate assessment of treatment response in patients undergoing locoregional therapy (LRT). The goal is to assess how PSMA PET/CT may impact clinical decision-making, staging, and management of HCC across multiple stages of disease.
Sponsor: VA Office of Research and Development
Yes, this clinical trial (NCT07019844) has an active research site in West Los Angeles, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hepatocellular carcinoma (hcc) treatment options in West Los Angeles, CA, this clinical trial (NCT07019844) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our West Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatocellular carcinoma (hcc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hepatocellular carcinoma (hcc) clinical trials near you to find additional studies recruiting in your area.
See all liver cancer clinical trials recruiting in West Los Angeles — not just this study.
Browse Liver Cancer Trials in West Los Angeles →